Osteopenia: A common aspect of Fabry disease. Predictors of bone mineral density

Genetics in Medicine

Volumn 9, Issue 12, 2007, Pages 812-818

  Mersebach, Henriette ^a   Johansson, Jan Ove ^b   Rasmussen, Åse Krogh ^a   Bengtsson, Bengt Åke ^b   Rosenberg, Kirsten ^c   Hasholt, Lis ^c   Sørensen, Sven Asger ^c   Sørensen, Søren Schwartz ^a   Feldt Rasmussen, Ulla ^a,d  

^a Mental Health Services CPH   (Denmark)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Bone mineral density; Dexa scan; Fabry disease; Osteopenia; Osteoporosis; Parathyroid hormone

Indexed keywords

ETHYLENEDIAMINE; OSTEOCALCIN; PARATHYROID HORMONE; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE METABOLISM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FABRY DISEASE; FEMALE; FEMUR NECK; GENOTYPE; HIP; HUMAN; HYPERPARATHYROIDISM; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OSTEOPENIA; OSTEOPOROSIS; PREDICTION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE DENSITY; BONE DISEASES, METABOLIC; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FABRY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 37349083863     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e31815cb197     Document Type: Article

References (36)

1. Brady RO. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med 1967;276:1163-1167.
2. Desnick RJ, Ioannou AI, Eng CM. Alfa galactosidase deficiency. Fabry disease. In: Schriver CR, Beaudet AL, Sly WS, Valle D, et al., editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 2001.
3. Kaye EM. Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation. Ann Neurol 1988;23:505-509.
4. Crutchfield KE. Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 1998;50:1746-1749.
5. Eng CM. A phase 1/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet 2001;68:711-722.
6. Eng CM. Safety and efficacy of recombinant human alpha-galactosidase A - replacement therapy in Fabry's disease. N Engl J Med 2001;345:9-16.
7. Schiffmann R. Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci USA 2000;97:365-370.
8. Schiffmann R. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001;285:2743-2749.
9. Nelis GF. Anorexia, weight loss, and diarrhea as presenting symptoms of angiokeratoma corporis diffusum (Fabry-Anderson's disease). Dig Dis Sci 1989;34:1798-1800.
10. Thadhani R. Patients with Fabry disease on dialysis in the United States. Kidney Int 2002;6:249-255.
11. Germain DP. Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease. Clin Genet 2005;68:93-95.
12. Kanis JA. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
13. Juul A. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-752.
14. Germain DP, Benistan K, Khatchikian L, Mutschler C. Bone involvement in Fabry disease. Med Sci 2005;21:43-44.
15. Shiraki M. Relation between body size and bone mineral density with special reference to sex hormones and calcium regulating hormones in elderly females. Endocrinol Jpn 1991;38:343-349.
16. Reid IR, Legge M, Stapleton JP, Evans MC, et al. Regular exercise dissociates fat mass and bone density in premenopausal women. J Clin Endocrinol Metab 1995;80:1764-1768.
17. Nishizawa Y. Obesity as a determinant of regional bone mineral density. J Nutr Sci Vitaminol (Tokyo) 1991;37(suppl): S65-S70.
18. Sowers MF. Joint influence of fat and lean body composition compartments on femoral bone mineral density in premenopausal women. Am J Epidemiol 1992;136:257-265.
19. Urena P. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 2003;18:2325-2331.
20. Adams JE. Renal bone disease: radiological investigation. Kidney Int 1999;73:S38-S41.
21. Adams JE. Radiology of rickets and osteomalacia. In: Feldman D, Glorieux FH, Pike W, editors. Vitamin D. San Diego: Academic Press, 1997:619-642.
22. Rix M. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 1999;56:1084-1093.
23. Ohlsson C. Growth hormone and bone. Endocr Rev 1998;19:55-79.
24. Marcus R. Mechanisms of exercise effects on bone. In: Bilezikian JP, Raisz LG, Rogan GA, editors. Principles of bone biology. San Diego: Academic Press, 1996.
25. Schiffmann R. Pathophysiology and assessment of neuropathic pain in Fabry disease. Acta Paediatr 2002;91:48-52.
26. Inagaki M. Relative hypoxia of the extremities in Fabry disease. Brain Dev 1992;14:328-333.
27. Erdmann E. [Myocardial involvement in Fabry's disease (transl)]. Dtsch Med Wochenschr 1980;105:1618-1622.
28. Kayath MJ. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diabetes Complications 1994;8:97-104.
29. Forst T. Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabet Med 1995;12:874-879.
30. Pastores GM. Bone density in type 1 Gaucher disease. J Bone Miner Res 1996;11:1801-1807.
31. Ciana G. Bone marker alterations in patients with type 1 Gaucher disease. Calcif Tissue Int 2003;72:185-189.
32. Poll LW. Response of Gaucher bone disease to enzyme replacement therapy. Br J Radiol 2002;75(suppl 1):A25-A36.
33. Mendez MF. The vascular dementia of Fabry's disease. Dement Geriatr Cogn Disord 1997;8:252-257.
34. Bloomfield SE. Eye findings in the diagnosis of Fabry's disease. Patients with renal failure. JAMA 1978;240:647-649.
35. Sher NA. The ocular manifestations in Fabry's disease. Arch Ophthal 1979;97:671-676.
36. Sher NA. Central retinal artery occlusion complicating Fabry's disease. Arch Ophthal 1978;96:815-817.